Metraipolis › archive › dc_a7d1dfcf50df

Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TB — Europe PMC PMID:41847327

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41847327
DOI
10.5588/ijtldopen.25.0553
License (as archived)
solo-consultazione
Archived
2026-11-04T11:17:52.038Z
SHA-256 of the archived text
cc9b3120ac0014123dedc59538dfc4da50f8dea131fe440682e7d8344b49d42a
Stable URL of this page
https://metraipolis.com/documento/dc_a7d1dfcf50df

How to cite

Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TB — Europe PMC PMID:41847327 — Europe PMC (en), https://europepmc.org/article/MED/41847327 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a7d1dfcf50df (Metraipolis archive dc_a7d1dfcf50df, sha256 cc9b3120ac0014123dedc59538dfc4da50f8dea131fe440682e7d8344b49d42a)
BibTeX
@misc{dca7d1dfcf50df,
  title = {Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TB — Europe PMC PMID:41847327},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41847327},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a7d1dfcf50df; sha256 cc9b3120ac0014123dedc59538dfc4da50f8dea131fe440682e7d8344b49d42a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41847327. Agents can read the archived copy with the MCP tool read_document.